Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ergocalciferol
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lloydspharmacy Calcium & Vitamin D tablets
0906040N0BFABEE
|
Lloydspharmacy Calcium with Vitamin D | Ergocalciferol | Nutrition and Blood | No data available |
|
Osto-D2 50,000unit capsules
0906040N0BRAAFL
|
Osto-D2 | Ergocalciferol | Nutrition and Blood | No data available |
|
Seven Seas Calcium and Vitamin D chewable tablets
0906040N0BHAADX
|
Seven Seas Calcium with Vitamin D | Ergocalciferol | Nutrition and Blood | No data available |
|
Sterogyl 15H 600,000units/1.5ml inj ampoules
0906040N0CCAAFH
|
Sterogyl 15H | Ergocalciferol | Nutrition and Blood | No data available |
|
Uvesterol D 1,500units/ml oral solution
0906040N0CBAAFM
|
Uvesterol D | Ergocalciferol | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.